Harel Insurance Investments & Financial Services’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-284
Closed -$4K 724
2022
Q3
$4K Sell
284
-43
-13% -$850 ﹤0.01% 680
2022
Q2
$9K Sell
327
-29
-8% -$859 ﹤0.01% 674
2022
Q1
$13K Sell
356
-67
-16% -$2.96K ﹤0.01% 652
2021
Q4
$26K Buy
+423
New +$32.1K ﹤0.01% 658
2021
Q2
Sell
-6,082
Closed -$991K 840
2021
Q1
$991K Sell
6,082
-18
-0.3% -$868 0.02% 359
2020
Q4
$611K Sell
6,100
-16,300
-73% -$399K 0.01% 334
2020
Q3
$467K Buy
+22,400
New +$385K 0.02% 202

Other funds holding OPRX

Harel Insurance Investments & Financial Services's OPRX Position: Q4 2022 in Review

Harel Insurance Investments & Financial Services sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 284 shares — an estimated $4K sold.

Harel Insurance Investments & Financial Services first reported a position in OPRX in Q3 2020 and held it in 7 quarters. The position peaked at $991K in Q1 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

  • Harel Insurance Investments & Financial Services reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 284 OptimizeRx shares in Q4 2022, an estimated $4K.
  • Harel Insurance Investments & Financial Services first reported a position in OptimizeRx in Q3 2020 and held it in 7 quarters.
  • Harel Insurance Investments & Financial Services's OptimizeRx position peaked at $991K in Q1 2021.
  • 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2022, filed 26 Jan 2023.